Search clinical trials for: ARQ 501
Total 8338 results
-
Auregen Biotherapeutics, SARecruitingMicrotiaUnited States
-
Auregen Biotherapeutics, SARecruiting
-
Betta Pharmaceuticals Co., Ltd.Recruiting
-
Innovo Therapeutics, Inc.Recruiting
-
Kiora Pharmaceuticals, Inc.RecruitingRetinitis Pigmentosa | ChoroideremiaAustralia
-
Stoke Therapeutics, IncEnrolling by invitationDravet SyndromeUnited States
-
CorrectSequence Therapeutics Co., LtdFirst Affiliated Hospital of Guangxi Medical UniversityActive, not recruiting
-
Blue Blood Biotech Corp.Completed
-
Paean Biotechnology Inc.CompletedDermatomyositis | PolymyositisKorea, Republic of
-
MedRhythms, Inc.Active, not recruitingChronic StrokeUnited States
-
Auregen Biotherapeutics, SAEnrolling by invitation
-
Fervent PharmaceuticalsICON plcCompletedVasomotor Symptoms | MenopauseUnited States
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
Dr. Anupam SehgalTaysha Gene Therapies, Inc.; GlycoNetActive, not recruitingInfantile GM2 Gangliosidosis (Disorder)Canada
-
Innovo Therapeutics, Inc.Completed
-
Invenux, LLCState University of New York - Downstate Medical CenterActive, not recruitingSickle Cell Disease | Sickle-Beta Zero ThalassemiaUnited States
-
Drägerwerk AG & Co. KGaAUniversity of Göttingen; Prof. Dr. med. ImhoffSuspendedMechanical Ventilation | Ventilation Perfusion MismatchGermany
-
Ossium Health, Inc.Withdrawn
-
Adicet Bio, IncEnrolling by invitationLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell LymphomaUnited States
-
Abeona Therapeutics, IncTerminatedMucopolysaccharidosis III-BUnited States, Germany, France
-
Lumen Bioscience, Inc.CompletedC. Diff. InfectionsAustralia
-
Forte Biosciences, Inc.Terminated
-
PfizerCompletedReduction in Hypertrophic Skin ScarringUnited States
-
Stargazer Pharmaceuticals, Inc.Completed
-
AL-S PharmaUnknownAmyotrophic Lateral SclerosisCanada
-
Otonomy, Inc.Completed
-
United BioSource, LLCAveXis, Inc.Approved for marketing
-
ADC Therapeutics S.A.TerminatedAdvanced Solid TumorsUnited States
-
Benitec BioPharma LtdCompletedHead and Neck Squamous Cell CarcinomaAustralia, Russian Federation
-
Amma Owusu-Ansah, MDNuvOx LLC; Noguchi Memorial Institute for Medical ResearchWithdrawnSickle Cell Disease
-
ESSA PharmaceuticalsTerminatedGenital Neoplasms, Male | Prostatic Neoplasms | Prostatic Diseases | Genital Diseases, MaleUnited States, Canada
-
Curis, Inc.Terminated
-
Minerva NeurosciencesCompletedHealthy SubjectsIreland
-
LYSOGENECompletedMucopolysaccharidosis Type III A | Sanfilippo Disease Type AFrance
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
LYSOGENECompletedMucopolysaccharidosis Type III A | Sanfilippo Disease Type AFrance
-
HealthpointCompleted
-
Cerenis Therapeutics, SACompleted
-
HealthpointTerminatedSkin AbnormalitiesUnited States
-
Zeria PharmaceuticalCompletedPrimary Hypophosphatemic RicketsJapan
-
Infinity Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Infinity Pharmaceuticals, Inc.Completed
-
Sangamo TherapeuticsCompletedAmyotrophic Lateral SclerosisUnited States
-
NorgineCompletedPostoperative IleusUnited Kingdom
-
M.D. Anderson Cancer CenterAlaunos TherapeuticsCompleted
-
C.B. Fleet Company, Inc.CompletedBowel Cleansing Prior to ColonoscopyUnited States
-
AmgenCompletedCancer | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Thrombocytopenia | Oncology | Chemotherapy-Induced Thrombocytopenia
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAlzheimer DiseaseNetherlands
-
Danube Pharmaceuticals, Inc.CompletedOcular Hypertension | Glaucoma | Elevated IOPUnited Kingdom